3 Min Read
NEW YORK (Reuters Health) - Thousands of lives could be saved every year if the US were to donate used pacemakers to developing countries instead of throwing them in the trash, doctors say.
The US Food and Drug Administration currently prohibits reuse of pacemakers from dead people, in part because of the risk of infection. According to experts, this policy is supported by manufacturers and many physicians.
But at a meeting on Thursday, doctors from the University of Michigan in Ann Arbor presented pooled data from hundreds of patients showing there was no increase in infections, malfunctioning or overall complications when reusing pacemakers.
"This is a potentially life-saving technology that we are just throwing away right now," said Dr. Kim A. Eagle, a cardiologist who worked on the study.
Heart disease is traditionally considered a product of a Western lifestyle, but is on the rise in other parts of the world as well, Eagle told Reuters Health. He added that certain parasitic diseases also cause heart trouble.
"It's estimated that there are a million deaths a year from people in low- and middle-income countries due to slow heart rhythms," he said.
The FDA does not regulate export of pacemakers from cadavers, and so far the Michigan doctors have tested reused devices in about a dozen patients in the Philippines with good results.
A pacemaker costs from $3,500 up to $30,000 in the US, depending on the type. Eagle said this price was prohibitive in developing nations, even though they often have the medical expertise to treat patients.
Instead of throwing away the devices, as is common practice at funeral homes according to Eagle, his team has offered to help sterilize and test them for reuse.
This offer clashes with guidelines from the Heart Rhythm Society, which recommends that pacemakers be returned to manufacturers for testing. But manufacturers do not recycle their products, experts say.
In a telephone interview with Reuters Health, Dr. Richard L. Page, immediate past president of the society, said he did not recall the guidelines in detail. But given the reassuring findings, he said it was less important who did the testing and sterilizing, as long as somebody did it.
"When given a choice I would rather put in a new device in a patient, but I have had the luxury of practicing in the United States," he said, adding that reuse "is clearly preferred over failure to treat, especially now that we have data to suggest it is safe."
It is unclear, however, how patients getting a reused pacemaker would be insured against malfunctioning.
SOURCE: American Heart Association, Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke 2010 Scientific Sessions, May 20, 2010.